Showing results (191-200 of 274) with videos related to

Sort By:
Pageof 28
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 20, 1997
[Calcium channel blockers in heart failure]T Hole, K Dickstein, T Gundersen, et al.
Journal of the American College of Cardiology|August 26, 1998
Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) studyP A Sirnes, S Golf, Y Myreng, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?T Wethal, H S Haugnes, J Kjekshus, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 10, 1997
[Treatment of heart failure with beta-blockaders]T Gundersen, K Dickstein, T Hole, et al.
Circulation|December 19, 2001
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4SC M Ballantyne, A G Olsson, T J Cook, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1995
[Chronic left heart ventricle failure and inotropic stimulation]E S Myhre, T Gundersen, K Dickstein, et al.
The American Journal of Medicine|June 1, 1984
Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balanceD W Wahr, K Swedberg, M Rabbino, et al.
International Journal of Cardiology|November 15, 2013
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT studyL Tavazzi, K Swedberg, M Komajda, et al.
Journal of the Autonomic Nervous System|August 1, 1998
Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantationL Gullestad, H Aass, H Ross, et al.
European Journal of Heart Failure|June 12, 2003
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programmeJ McMurray, J Ostergren, M Pfeffer, et al.
Pageof 28